Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EYES (Vision Twenty-One, Inc.) -- Ignore unavailable to you. Want to Upgrade?

To: 007 who wrote (31)	5/8/1998 12:22:00 PM
From: Sword	Read Replies (1) \| Respond to of 129

Strong revenue growth and earnings, met expectations, stock is undervalued. I bought many blocks at 7 3/4.

To: 007 who wrote (31)	5/8/1998 3:12:00 PM
From: Shelia Jones	Read Replies (1) \| Respond to of 129

Hi 007 and thread, Talked to Heidi (she's from Walnut Creek - my home away from home) also. While she agreed that earnings were in line with first call, .11, she also said the table from the S&P yahoo release was accurate as well. They included the merger costs in the "inc. bef. extrord item" - as you well know - so it is technically correct as printed. However, she did allude to a lot of phone calls concerning what may be called confusion (she was careful with her wording) with the 8 vs. 11 cent listings. Hope the EYES have it.